Comparative short-term prognostic value of hemostatic and inflammatory markers in patients with non-ST elevation acute coronary syndromes

Italian Heart Journal

Volumn 3, Issue 1, 2002, Pages 28-33

  Passoni, Federico ^a   Morelli, Benedetto ^a   Seveso, Giovanni ^a   Lazzati, Luisa ^a   Beria, Gabriella ^a   Del Rosso, Gianfranco ^a   D'Urbano, Maurizio ^a   Cafiero, Francesco ^a   Mariani, Giuseppe ^a   De Servi, Stefano ^a  

^a Ospedale Civile   (Italy)

Author keywords

Coagulation system; Inflammation; Unstable angina

Indexed keywords

BIOCHEMICAL MARKER; INTERLEUKIN 6; PLASMINOGEN ACTIVATOR INHIBITOR; TROPONIN I; VON WILLEBRAND FACTOR;

ADULT; AGED; ANGIOCARDIOGRAPHY; AREA UNDER THE CURVE; ARTICLE; BIOCHEMISTRY; BLOOD CLOTTING; BLOOD LEVEL; BLOOD SAMPLING; CAUSE OF DEATH; CONTROLLED STUDY; CORONARY CARE UNIT; FEMALE; FIBRINOLYSIS; HEART INFARCTION; HEART MUSCLE ISCHEMIA; HEMOSTASIS; HOSPITAL ADMISSION; HUMAN; INFLAMMATION; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; OUTCOMES RESEARCH; PREDICTION; PROGNOSIS; RECEIVER OPERATING CHARACTERISTIC; ST SEGMENT ELEVATION; THORAX PAIN; UNSTABLE ANGINA PECTORIS;

AGED; ANGINA, UNSTABLE; BIOLOGICAL MARKERS; CORONARY ANGIOGRAPHY; FEMALE; FIBRIN FIBRINOGEN DEGRADATION PRODUCTS; HUMANS; INTERLEUKIN-6; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; PLASMINOGEN ACTIVATOR INHIBITOR 1; PREDICTIVE VALUE OF TESTS; PROGNOSIS; TIME FACTORS; TROPONIN I; VON WILLEBRAND FACTOR;

EID: 0036204030     PISSN: 1129471X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Unstable angina. An etiologic approach to management
2. Acute coronary syndromes. Unstable angina and non-Q wave myocardial infarction
3. Mechanisms leading to myocardial infarction: Insights from studies of vascular biology
4. Molecular basis of the acute coronary syndromes
5. Inflammatory status as a main determinant of outcome in patients with unstable angina, independent of coagulation activation and endothelial cell function
6. Thrombin activity and early outcome in unstable angina pectoris
7. The prognostic value of C-reactive protein and serum amyloid A protein in severe unstable angina
8. Prognostic value of plasma fibrinogen concentration in patients with unstable angina and non-Q wave myocardial infarction
9. Prognostic influence of increased fibrinogen and C-reactive protein levels in unstable coronary artery disease
10. Markers of myocardial damage and inflammation in relation to long-term mortality in unstable coronary disease
11. Increasing levels of interleukin (IL)-1Ra and IL-6 during the first 2 days of hospitalization in unstable angina are associated with increased risk of in-hospital coronary events
12. Early increase of von Willebrand factor predicts adverse outcome in unstable coronary artery disease. Beneficial effects of enoxaparin
13. Acute T-cell activation is detectable in unstable angina
14. Increased expression of neutrophil and monocyte adhesion molecules in unstable coronary artery disease
15. Clinical and angiographic correlates of leukocyte activation in unstable angina
16. Procoagulant and proinflammatory activity in acute coronary syndromes
17. Elevated levels of interleukin-6 in unstable angina
18. Elevated levels of C-reactive protein at discharge in patients with unstable angina predict recurrent instability
19. Persistent activation of coagulation mechanism in unstable angina and myocardial infarction
20. Temporal relation between ischemic episodes and activation of the coagulation system in unstable angina
21. Evidence for reduced fibrinolytic activity in unstable angina at rest. Clinical, biochemical, and angiographic correlates
22. Alteration of coagulation and fibrinolytic and kallikrein-kinin systems in the acute and postacute phases in patients with unstable angina pectoris
23. A depression of active tissue plasminogen activator in plasma characterizes patients with unstable angina pectoris who develop myocardial infarction
24. Increased plasma levels of a rapid inhibitor of tissue plasminogen activator in young survivors of myocardial infarction
25. The PLAT Study: Hemostatic function in relation to atherothrombotic ischemic events in vascular disease patients. Principal results
26. Willebrand factor in plasma: A novel risk factor for recurrent myocardial infarction and death
27. Hemostatic factors and the risk of myocardial infarction or sudden death in patients with angina pectoris
28. Benefit of abciximab in patients with refractory unstable angina in relation to serum troponin T levels